Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2475

TR 346 Rat Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                           ETHYL CHLORIDE


NTP Experiment-Test: 05078-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/10/94
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15




       Facility:  Battelle Northwest

       Chemical CAS #:  75-00-3

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                19           24                                                               
    Natural Death                                                   4                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                31           22                                                               
  Animals Examined Microscopically                    50           50                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large                                    (50)         (49)                                                             
      Anus, Parasite Metazoan                                       1 (2%)                                                          
   Intestine Large, Cecum                             (50)         (48)                                                             
      Parasite Metazoan                                7 (14%)      6 (13%)                                                         
   Intestine Large, Colon                             (50)         (49)                                                             
      Parasite Metazoan                                4 (8%)       7 (14%)                                                         
   Intestine Large, Rectum                            (48)         (44)                                                             
      Parasite Metazoan                                6 (13%)      3 (7%)                                                          
   Liver                                              (50)         (50)                                                             
      Angiectasis                                      1 (2%)       1 (2%)                                                          
      Basophilic Focus                                29 (58%)     22 (44%)                                                         
      Congestion                                                    1 (2%)                                                          
      Degeneration                                     2 (4%)       2 (4%)                                                          
      Degeneration, Fatty                             10 (20%)      6 (12%)                                                         
      Hematopoietic Cell Proliferation                 3 (6%)       5 (10%)                                                         
      Hepatodiaphragmatic Nodule                       3 (6%)                                                                       
      Inflammation, Focal, Granulomatous              19 (38%)     21 (42%)                                                         
      Leukocytosis                                     3 (6%)       1 (2%)                                                          
      Necrosis                                         2 (4%)       8 (16%)                                                         
      Pigmentation                                                  1 (2%)                                                          
      Thrombosis                                       2 (4%)                                                                       
      Bile Duct, Hyperplasia                           7 (14%)     12 (24%)                                                         
      Hepatocyte, Hyperplasia                          2 (4%)                                                                       
   Mesentery                                          (1)          (2)                                                              
      Fat, Inflammation, Chronic                       1 (100%)     1 (50%)                                                         
   Pancreas                                           (49)         (50)                                                             
      Atrophy                                         15 (31%)      9 (18%)                                                         
      Cytomegaly                                       1 (2%)       2 (4%)                                                          
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation                                     1 (2%)                                                                       
      Artery, Mineralization                                        1 (2%)                                                          
   Pharynx                                                         (2)                                                              
      Palate, Inflammation, Chronic                                 1 (50%)                                                         
   Salivary Glands                                    (48)         (50)                                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Chronic, Suppurative               1 (2%)                                                                       
      Duct, Hyperplasia                                4 (8%)       6 (12%)                                                         
   Stomach, Forestomach                               (46)         (50)                                                             
      Inflammation, Chronic                            2 (4%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Ulcer                                            1 (2%)       1 (2%)                                                          
      Epithelium, Hyperplasia                          6 (13%)      1 (2%)                                                          
   Stomach, Glandular                                 (50)         (49)                                                             
      Mineralization                                                1 (2%)                                                          
      Ulcer                                                         1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                    (1)                                                              
      Inflammation                                                  1 (100%)                                                        
   Heart                                              (50)         (50)                                                             
      Inflammation, Chronic                           42 (84%)     41 (82%)                                                         
      Artery, Mineralization                                        1 (2%)                                                          
      Atrium, Thrombosis                                            2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)                                                             
      Degeneration                                                  1 (2%)                                                          
      Degeneration, Fatty                             13 (26%)     18 (36%)                                                         
      Focal Cellular Change                            1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 5 (10%)      6 (12%)                                                         
      Hemorrhage                                                    1 (2%)                                                          
      Hyperplasia                                      6 (12%)      9 (18%)                                                         
      Hypertrophy                                      1 (2%)       1 (2%)                                                          
      Necrosis                                         1 (2%)                                                                       
   Adrenal Gland, Medulla                             (35)         (40)                                                             
      Hyperplasia                                      4 (11%)      3 (8%)                                                          
      Necrosis                                         1 (3%)                                                                       
   Islets, Pancreatic                                 (49)         (50)                                                             
      Hyperplasia                                      1 (2%)                                                                       
   Parathyroid Gland                                  (34)         (31)                                                             
      Hyperplasia                                                   1 (3%)                                                          
   Pituitary Gland                                    (49)         (50)                                                             
      Pars Distalis, Cyst                              3 (6%)       4 (8%)                                                          
      Pars Distalis, Hemorrhage                                     1 (2%)                                                          
      Pars Distalis, Hyperplasia                      10 (20%)     11 (22%)                                                         
      Pars Distalis, Infiltration Cellular, Mixed                                                                                   
          Cell                                                      1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Pars Distalis, Metaplasia, Osseous               1 (2%)                                                                       
      Pars Distalis, Pigmentation, Hemosiderin         1 (2%)       2 (4%)                                                          
   Thyroid Gland                                      (49)         (48)                                                             
      Mineralization                                                1 (2%)                                                          
      C-Cell, Hyperplasia                             33 (67%)     31 (65%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (46)         (43)                                                             
      Cyst                                             2 (4%)                                                                       
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                        4 (9%)       3 (7%)                                                          
      Duct, Hyperplasia                                1 (2%)       1 (2%)                                                          
   Ovary                                              (49)         (50)                                                             
      Atrophy                                          1 (2%)       4 (8%)                                                          
      Cyst                                             2 (4%)       5 (10%)                                                         
      Interstitium, Hyperplasia                        2 (4%)       1 (2%)                                                          
   Uterus                                             (49)         (50)                                                             
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Endometrium, Hyperplasia                         1 (2%)       1 (2%)                                                          
      Endometrium, Hyperplasia, Cystic                 1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)                                                             
      Infiltration Cellular, Histiocyte                             1 (2%)                                                          
      Myelofibrosis                                    2 (4%)                                                                       
   Lymph Node                                         (48)         (49)                                                             
      Mesenteric, Angiectasis                          1 (2%)                                                                       
      Mesenteric, Inflammation, Granulomatous          1 (2%)                                                                       
      Renal, Inflammation, Granulomatous               1 (2%)                                                                       
   Lymph Node, Bronchial                              (47)         (47)                                                             
      Congestion                                       1 (2%)       1 (2%)                                                          
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Granulomatous                      1 (2%)                                                                       
   Lymph Node, Mandibular                             (39)         (43)                                                             
      Angiectasis                                      1 (3%)                                                                       
      Depletion Cellular                                            1 (2%)                                                          
      Hyperplasia                                      9 (23%)      8 (19%)                                                         
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Spleen                                             (50)         (50)                                                             
      Fibrosis                                         1 (2%)                                                                       
      Hematocyst                                                    1 (2%)                                                          
      Hematopoietic Cell Proliferation                 1 (2%)       7 (14%)                                                         
      Inflammation, Focal, Granulomatous               1 (2%)       2 (4%)                                                          
      Pigmentation, Hemosiderin                                     2 (4%)                                                          
   Thymus                                             (38)         (39)                                                             
      Epithelial Cell, Hyperplasia                     1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (48)         (50)                                                             
      Hyperplasia                                     45 (94%)     47 (94%)                                                         
   Skin                                               (47)         (49)                                                             
      Acanthosis                                       2 (4%)       2 (4%)                                                          
      Inflammation                                     1 (2%)                                                                       
      Inflammation, Suppurative                                     3 (6%)                                                          
      Subcutaneous Tissue, Inflammation, Chronic       1 (2%)                                                                       
      Subcutaneous Tissue, Inflammation,                                                                                            
          Granulomatous                                1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)                                                             
      Fibrous Osteodystrophy                                        1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)                                                             
      Gliosis                                                       1 (2%)                                                          
      Hemorrhage, Focal                                2 (4%)       2 (4%)                                                          
      Inflammation                                                  1 (2%)                                                          
      Necrosis, Focal                                  1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (49)                                                             
      Inflammation, Suppurative                       10 (20%)      7 (14%)                                                         
      Metaplasia, Squamous                             1 (2%)                                                                       
      Epithelium, Hyperplasia                                       2 (4%)                                                          
      Submucosa, Inflammation                          1 (2%)       1 (2%)                                                          
   Lung                                               (50)         (50)                                                             
      Congestion                                                    2 (4%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Edema                                            1 (2%)       2 (4%)                                                          
      Foreign Body                                     1 (2%)                                                                       
      Hemorrhage                                                    4 (8%)                                                          
      Infiltration Cellular, Histiocyte                8 (16%)     13 (26%)                                                         
      Inflammation, Chronic, Diffuse                   1 (2%)       1 (2%)                                                          
      Inflammation, Chronic, Focal                     4 (8%)       4 (8%)                                                          
      Inflammation, Granulomatous                      1 (2%)                                                                       
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
      Thrombosis                                                    1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 4 (8%)       8 (16%)                                                         
      Bronchiole, Epithelium, Hyperplasia                           1 (2%)                                                          
      Mediastinum, Infiltration Cellular,                                                                                           
          Mononuclear Cell                             1 (2%)                                                                       
      Perivascular, Infiltration Cellular,                                                                                          
          Mononuclear Cell                            21 (42%)     19 (38%)                                                         
   Nose                                               (50)         (50)                                                             
      Inflammation, Suppurative                        6 (12%)      6 (12%)                                                         
      Thrombosis                                       2 (4%)       5 (10%)                                                         
      Nasolacrimal Duct, Inflammation, Suppurative    12 (24%)     10 (20%)                                                         
      Respiratory Epithelium, Hyperplasia              4 (8%)      10 (20%)                                                         
      Respiratory Epithelium, Metaplasia, Squamous     2 (4%)       1 (2%)                                                          
      Submucosa, Inflammation                         25 (50%)     34 (68%)                                                         
      Vomeronasal Organ, Inflammation, Suppurative     1 (2%)       1 (2%)                                                          
   Trachea                                            (50)         (49)                                                             
      Inflammation, Suppurative                        2 (4%)       1 (2%)                                                          
      Epithelium, Hyperplasia                                       1 (2%)                                                          
      Submucosa, Inflammation                                       2 (4%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (3)          (5)                                                              
      Cataract                                         1 (33%)      2 (40%)                                                         
      Hemorrhage                                                    1 (20%)                                                         
      Inflammation, Chronic                                         1 (20%)                                                         
      Synechia                                         1 (33%)      1 (20%)                                                         
      Bilateral, Cataract                              1 (33%)      1 (20%)                                                         
      Retina, Atrophy                                  1 (33%)      2 (40%)                                                         
   Harderian Gland                                                 (1)                                                              
      Inflammation, Suppurative                                     1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)                                                             
      Hydronephrosis                                                1 (2%)                                                          
      Inflammation, Suppurative                        2 (4%)                                                                       
      Mineralization                                                1 (2%)                                                          
      Nephropathy                                     47 (94%)     42 (84%)                                                         
      Renal Tubule, Hyperplasia, Focal                 1 (2%)       2 (4%)                                                          
   Urinary Bladder                                    (49)         (49)                                                             
      Hemorrhage                                                    1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50                                                               
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                28           33                                                               
    Natural Death                                      6            9                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                16            8                                                               
  Animals Examined Microscopically                    50           50                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (49)         (45)                                                             
      Parasite Metazoan                                8 (16%)      4 (9%)                                                          
   Intestine Large, Colon                             (50)         (45)                                                             
      Parasite Metazoan                                5 (10%)      5 (11%)                                                         
   Intestine Large, Rectum                            (47)         (43)                                                             
      Parasite Metazoan                                4 (9%)       5 (12%)                                                         
      Serosa, Inflammation, Chronic                    1 (2%)       1 (2%)                                                          
      Serosa, Thrombosis                               1 (2%)                                                                       
   Liver                                              (50)         (50)                                                             
      Angiectasis                                                   1 (2%)                                                          
      Basophilic Focus                                18 (36%)      7 (14%)                                                         
      Clear Cell Focus                                 3 (6%)       2 (4%)                                                          
      Congestion                                                    2 (4%)                                                          
      Degeneration                                     2 (4%)       2 (4%)                                                          
      Degeneration, Cystic                             3 (6%)       9 (18%)                                                         
      Degeneration, Fatty                              9 (18%)      5 (10%)                                                         
      Fibrosis                                         1 (2%)                                                                       
      Hematopoietic Cell Proliferation                              3 (6%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Hepatodiaphragmatic Nodule                       2 (4%)       2 (4%)                                                          
      Inflammation, Focal, Granulomatous               6 (12%)      5 (10%)                                                         
      Necrosis                                         7 (14%)      4 (8%)                                                          
      Pigmentation                                                  1 (2%)                                                          
      Bile Duct, Hyperplasia                          44 (88%)     34 (68%)                                                         
      Hepatocyte, Hyperplasia                          3 (6%)       8 (16%)                                                         
   Pancreas                                           (50)         (49)                                                             
      Atrophy                                         24 (48%)     17 (35%)                                                         
      Cytomegaly                                       2 (4%)       1 (2%)                                                          
      Inflammation                                                  1 (2%)                                                          
      Pigmentation, Hemosiderin                        1 (2%)       1 (2%)                                                          
      Artery, Intima, Hyperplasia                      1 (2%)                                                                       
      Perivascular, Inflammation                                    3 (6%)                                                          
   Pharynx                                            (2)          (1)                                                              
      Inflammation, Suppurative                                     1 (100%)                                                        
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Palate, Inflammation, Chronic                    2 (100%)                                                                     
   Salivary Glands                                    (50)         (50)                                                             
      Duct, Hyperplasia                               10 (20%)     15 (30%)                                                         
      Duct, Inflammation, Suppurative                  2 (4%)       1 (2%)                                                          
   Stomach, Forestomach                               (48)         (49)                                                             
      Hyperkeratosis                                                1 (2%)                                                          
      Inflammation, Chronic                            2 (4%)                                                                       
      Inflammation, Suppurative                        3 (6%)       1 (2%)                                                          
      Ulcer                                            4 (8%)       1 (2%)                                                          
      Epithelium, Hyperplasia                          2 (4%)       2 (4%)                                                          
      Serosa, Inflammation, Chronic                                 1 (2%)                                                          
   Stomach, Glandular                                 (50)         (50)                                                             
      Erosion                                                       3 (6%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Mineralization                                                2 (4%)                                                          
      Epithelium, Hyperplasia                                       1 (2%)                                                          
      Serosa, Inflammation, Chronic                                 1 (2%)                                                          
   Tooth                                              (3)                                                                           
      Gingiva, Hyperplasia, Pseudoepitheliomatous      1 (33%)                                                                      
      Peridontal Tissue, Inflammation, Chronic,                                                                                     
           Suppurative                                 2 (67%)                                                                      
      Pulp, Inflammation, Suppurative                  1 (33%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)                                                             
      Inflammation, Chronic                           43 (86%)     46 (92%)                                                         
      Artery, Mineralization                                        1 (2%)                                                          
      Atrium, Thrombosis                               2 (4%)       2 (4%)                                                          
      Perivascular, Inflammation                       1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)                                                             
      Degeneration, Fatty                             23 (46%)     26 (52%)                                                         
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)                                                          
      Hyperplasia                                     13 (26%)      6 (12%)                                                         
      Hypertrophy                                      2 (4%)                                                                       
   Adrenal Gland, Medulla                             (36)         (48)                                                             
      Hematopoietic Cell Proliferation                              1 (2%)                                                          
      Hyperplasia                                     11 (31%)     16 (33%)                                                         
   Islets, Pancreatic                                 (48)         (48)                                                             
      Hyperplasia                                      3 (6%)       4 (8%)                                                          
   Parathyroid Gland                                  (31)         (41)                                                             
      Hyperplasia                                                   3 (7%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Pituitary Gland                                    (49)         (50)                                                             
      Pars Distalis, Cyst                              1 (2%)       2 (4%)                                                          
      Pars Distalis, Hemorrhage                        1 (2%)       1 (2%)                                                          
      Pars Distalis, Hyperplasia                      10 (20%)     10 (20%)                                                         
      Pars Distalis, Inflammation, Suppurative                      1 (2%)                                                          
      Pars Distalis, Necrosis                          1 (2%)                                                                       
      Pars Distalis, Pigmentation, Hemosiderin                      1 (2%)                                                          
   Thyroid Gland                                      (49)         (47)                                                             
      C-Cell, Hyperplasia                             19 (39%)     23 (49%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   Tissue NOS                                         (1)          (4)                                                              
      Inflammation, Chronic                            1 (100%)     1 (25%)                                                         
      Necrosis                                         1 (100%)     1 (25%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (37)         (42)                                                             
      Granuloma Sperm                                               1 (2%)                                                          
      Inflammation, Chronic                            1 (3%)                                                                       
      Mineralization                                   1 (3%)                                                                       
      Vacuolization Cytoplasmic                       14 (38%)     15 (36%)                                                         
   Penis                                                           (1)                                                              
      Inflammation, Suppurative                                     1 (100%)                                                        
   Preputial Gland                                    (47)         (45)                                                             
      Cyst                                             1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                       10 (21%)      3 (7%)                                                          
      Duct, Hyperplasia                                             1 (2%)                                                          
   Prostate                                           (50)         (48)                                                             
      Hyperplasia                                      4 (8%)      11 (23%)                                                         
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                       16 (32%)     13 (27%)                                                         
   Seminal Vesicle                                    (7)          (6)                                                              
      Inflammation, Suppurative                        7 (100%)     5 (83%)                                                         
   Testes                                             (50)         (50)                                                             
      Atrophy                                         27 (54%)     29 (58%)                                                         
      Interstitial Cell, Hyperplasia                  12 (24%)     15 (30%)                                                         
      Perivascular, Inflammation                       3 (6%)       8 (16%)                                                         
      Tunic, Hyperplasia                                            1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (48)                                                             
      Hyperplasia                                                   1 (2%)                                                          
      Myelofibrosis                                    1 (2%)       1 (2%)                                                          
   Lymph Node                                         (49)         (50)                                                             
      Mesenteric, Hematopoietic Cell Proliferation     1 (2%)                                                                       
      Mesenteric, Inflammation, Granulomatous                       1 (2%)                                                          
      Pancreatic, Hyperplasia                          1 (2%)                                                                       
      Renal, Hematopoietic Cell Proliferation          1 (2%)                                                                       
   Lymph Node, Bronchial                              (42)         (48)                                                             
      Hyperplasia                                      2 (5%)       2 (4%)                                                          
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
   Lymph Node, Mandibular                             (45)         (38)                                                             
      Angiectasis                                      1 (2%)       2 (5%)                                                          
      Hyperplasia                                     19 (42%)     11 (29%)                                                         
   Spleen                                             (50)         (50)                                                             
      Fibrosis                                         3 (6%)       9 (18%)                                                         
      Hematocyst                                                    1 (2%)                                                          
      Hematopoietic Cell Proliferation                 2 (4%)       2 (4%)                                                          
   Thymus                                             (39)         (41)                                                             
      Epithelial Cell, Hyperplasia                     1 (3%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (13)         (14)                                                             
      Galactocele                                                   3 (21%)                                                         
      Hyperplasia                                      8 (62%)     10 (71%)                                                         
   Skin                                               (49)         (46)                                                             
      Acanthosis                                       1 (2%)                                                                       
      Ectopic Tissue                                                1 (2%)                                                          
      Inflammation, Chronic                            1 (2%)       1 (2%)                                                          
      Pigmentation, Hemosiderin                        1 (2%)                                                                       
      Prepuce, Abscess                                 1 (2%)                                                                       
      Prepuce, Epithelium, Hyperplasia                 1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (49)                                                             
      Fibrous Osteodystrophy                                        4 (8%)                                                          
      Hyperostosis                                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)                                                             
      Hemorrhage, Focal                                3 (6%)       3 (6%)                                                          
      Hydrocephalus                                    1 (2%)                                                                       
      Necrosis, Focal                                  2 (4%)                                                                       
      Meninges, Hemorrhage                             1 (2%)                                                                       
      Meninges, Inflammation, Suppurative              1 (2%)                                                                       
      Meninges, Pigmentation, Hemosiderin                           1 (2%)                                                          
   Spinal Cord                                                     (1)                                                              
      Degeneration                                                  1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (49)         (44)                                                             
      Inflammation, Suppurative                       14 (29%)     21 (48%)                                                         
      Metaplasia, Squamous                                          1 (2%)                                                          
   Lung                                               (50)         (50)                                                             
      Congestion                                       1 (2%)       5 (10%)                                                         
      Edema                                            1 (2%)       2 (4%)                                                          
      Erythrophagocytosis                                           1 (2%)                                                          
      Hemorrhage                                       4 (8%)       3 (6%)                                                          
      Infiltration Cellular, Histiocyte                5 (10%)     13 (26%)                                                         
      Infiltration Cellular, Mixed Cell                1 (2%)       1 (2%)                                                          
      Inflammation, Chronic, Focal                     4 (8%)       2 (4%)                                                          
      Metaplasia, Osseous                              1 (2%)       2 (4%)                                                          
      Alveolar Epithelium, Hyperplasia                 6 (12%)      7 (14%)                                                         
      Artery, Mediastinum, Mineralization                           1 (2%)                                                          
      Bronchiole, Inflammation, Suppurative                         1 (2%)                                                          
      Perivascular, Infiltration Cellular,                                                                                          
          Mononuclear Cell                             9 (18%)     14 (28%)                                                         
   Nose                                               (50)         (49)                                                             
      Edema                                            1 (2%)                                                                       
      Inflammation, Suppurative                       12 (24%)     13 (27%)                                                         
      Thrombosis                                       8 (16%)      7 (14%)                                                         
      Nasolacrimal Duct, Inflammation, Suppurative    12 (24%)      8 (16%)                                                         
      Respiratory Epithelium, Hyperplasia              9 (18%)     14 (29%)                                                         
      Respiratory Epithelium, Metaplasia, Squamous     1 (2%)                                                                       
      Submucosa, Inflammation                         22 (44%)     23 (47%)                                                         
      Vomeronasal Organ, Inflammation, Suppurative     2 (4%)       1 (2%)                                                          
   Trachea                                            (50)         (49)                                                             
      Inflammation, Suppurative                        2 (4%)       7 (14%)                                                         
      Epithelium, Hyperplasia                                       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05078-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                           ETHYL CHLORIDE                                      Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 13:04:15  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     CONTROL      15000 PP                                                            
                                                                M                                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (7)                                                              
      Cataract                                                      1 (14%)                                                         
      Degeneration                                     1 (100%)     1 (14%)                                                         
      Inflammation, Chronic                                         1 (14%)                                                         
      Synechia                                                      4 (57%)                                                         
      Bilateral, Cataract                                           3 (43%)                                                         
      Retina, Atrophy                                               3 (43%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)                                                             
      Fatty Change                                     1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 2 (4%)       3 (6%)                                                          
      Hydronephrosis                                                1 (2%)                                                          
      Inflammation, Suppurative                        4 (8%)       3 (6%)                                                          
      Nephropathy                                     49 (98%)     49 (98%)                                                         
      Pelvis, Inflammation, Suppurative                2 (4%)                                                                       
      Pelvis, Necrosis                                 1 (2%)                                                                       
      Pelvis, Epithelium, Hyperplasia                  1 (2%)       3 (6%)                                                          
   Urethra                                            (1)                                                                           
      Inflammation, Suppurative                        1 (100%)                                                                     
      Epithelium, Hyperplasia                          1 (100%)                                                                     
   Urinary Bladder                                    (50)         (49)                                                             
      Hemorrhage                                                    1 (2%)                                                          
      Inflammation                                                  1 (2%)                                                          
      Inflammation, Suppurative                        2 (4%)       1 (2%)                                                          
      Transitional Epithelium, Hyperplasia             1 (2%)       2 (4%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 84392-84392/84392


--multipart-boundary--